Bath Savings Trust’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $710K | Sell |
9,080
-2,455
| -21% | -$192K | 0.07% | 109 |
|
|
2025
Q1 | $836K | Sell |
11,535
-8,442
| -42% | -$612K | 0.09% | 100 |
|
|
2024
Q4 | $1.48M | Sell |
19,977
-32,577
| -62% | -$2.41M | 0.15% | 85 |
|
|
2024
Q3 | $3.47M | Sell |
52,554
-24,533
| -32% | -$1.62M | 0.34% | 59 |
|
|
2024
Q2 | $7.12M | Sell |
77,087
-9,828
| -11% | -$908K | 0.76% | 36 |
|
|
2024
Q1 | $8.31M | Sell |
86,915
-2,370
| -3% | -$226K | 0.88% | 34 |
|
|
2023
Q4 | $6.81M | Sell |
89,285
-4,185
| -4% | -$319K | 0.76% | 37 |
|
|
2023
Q3 | $6.48M | Sell |
93,470
-3,440
| -4% | -$238K | 0.8% | 34 |
|
|
2023
Q2 | $9.14M | Sell |
96,910
-5,120
| -5% | -$483K | 1.07% | 31 |
|
|
2023
Q1 | $8.44M | Sell |
102,030
-10,105
| -9% | -$836K | 1.04% | 32 |
|
|
2022
Q4 | $8.37M | Sell |
112,135
-615
| -0.5% | -$45.9K | 1.08% | 30 |
|
|
2022
Q3 | $9.32M | Sell |
112,750
-1,450
| -1% | -$120K | 1.3% | 27 |
|
|
2022
Q2 | $10.9M | Buy |
114,200
+85
| +0.1% | +$8.08K | 1.43% | 25 |
|
|
2022
Q1 | $13.4M | Buy |
114,115
+129
| +0.1% | +$15.2K | 1.53% | 22 |
|
|
2021
Q4 | $14.8M | Buy |
113,986
+52
| +0% | +$6.74K | 1.54% | 23 |
|
|
2021
Q3 | $12.9M | Buy |
113,934
+3,061
| +3% | +$347K | 1.49% | 25 |
|
|
2021
Q2 | $11.5M | Buy |
110,873
+3,620
| +3% | +$375K | 1.35% | 26 |
|
|
2021
Q1 | $8.97M | Buy |
107,253
+5,544
| +5% | +$464K | 1.15% | 30 |
|
|
2020
Q4 | $9.28M | Buy |
101,709
+2,247
| +2% | +$205K | 1.22% | 27 |
|
|
2020
Q3 | $7.94M | Buy |
99,462
+7,721
| +8% | +$616K | 1.3% | 27 |
|
|
2020
Q2 | $6.34M | Buy |
91,741
+5,500
| +6% | +$380K | 1.15% | 31 |
|
|
2020
Q1 | $5.42M | Buy |
86,241
+3,954
| +5% | +$249K | 1.17% | 31 |
|
|
2019
Q4 | $6.4M | Buy |
82,287
+756
| +0.9% | +$58.8K | 1.16% | 30 |
|
|
2019
Q3 | $5.98M | Buy |
81,531
+168
| +0.2% | +$12.3K | 1.15% | 31 |
|
|
2019
Q2 | $5.01M | Buy |
81,363
+5,847
| +8% | +$360K | 1% | 35 |
|
|
2019
Q1 | $4.82M | Buy |
75,516
+4,470
| +6% | +$285K | 1.02% | 34 |
|
|
2018
Q4 | $3.63M | Buy |
71,046
+2,562
| +4% | +$131K | 0.9% | 38 |
|
|
2018
Q3 | $3.98M | Buy |
68,484
+510
| +0.8% | +$29.6K | 0.87% | 39 |
|
|
2018
Q2 | $3.3M | Buy |
67,974
+2,370
| +4% | +$115K | 0.78% | 39 |
|
|
2018
Q1 | $3.05M | Buy |
65,604
+8,340
| +15% | +$388K | 0.76% | 40 |
|
|
2017
Q4 | $2.15M | Buy |
57,264
+16,920
| +42% | +$636K | 0.54% | 47 |
|
|
2017
Q3 | $1.47M | Buy |
40,344
+21,720
| +117% | +$791K | 0.39% | 55 |
|
|
2017
Q2 | $734K | Buy |
18,624
+11,319
| +155% | +$446K | 0.2% | 75 |
|
|
2017
Q1 | $229K | Buy |
+7,305
| New | +$229K | 0.07% | 108 |
|